Sientra Inc (SIEN)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

420 SOUTH FAIRVIEW AVENUE SANTA BARBARA, CA 93117

Sientra, Inc. manufactures and markets plastic surgery implantable devices. The Company focuses on developing plastic surgery and aesthetics medicine such as cosmetic and reconstructive surgical devices including breast implants, tissue expanders, body contouring implants, and other specialty products.

Data as of 2020-08-09
Market Cap209.64 Million Shares Outstanding50.033 Million Avg 30-day Volume1.063 Million
P/E Ratio Dividend Yield EPS-2.45
Price/Sales3.351 Price cash flow ratio98.9 Price free cash flow ratio-2.4
Book Value1.1 Price to Tangible Book5.94 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.077012
BETA1.56764 52-week High/Low9.71 / 1.0 Stddev0.237543
View SEC Filings from SIEN instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 89 31 (2.03%)
Aggregate 13F shares on 03/31/2020: 36.886 Million 14.857 Million
Aggregate 13F shares on 12/31/2019: 42.18 Million 18.697 Million
Percent change: -12.55% -20.54%
Funds creating new positions: 18 10
Funds Adding to an existing position: 28 9
Funds closing out their position: 36 19
Funds reducing their position: 28 9
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SIEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SIEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WILLIAMS PATRICK F. CHIEF FINANCIAL OFFICER

  • Officer
30,727 2020-08-10 0

SULLIVAN KEITH J PRESIDENT AND CEO

  • Officer
  • Director
0 2020-07-14 1

GREER R SCOTT

  • Director
176,574 2020-07-09 0

ABINGWORTH LLP

  • 10% Owner
10,302,602 2020-06-26 0

SIMON NICHOLAS

  • Director
  • 10% Owner
0 2020-06-18 1

OBOYLE KEVIN C

  • Director
100,802 2020-06-05 1

SCHAISON PHILIPPE

  • Director
90,862 2020-06-05 1

FISHER MARY

  • Director
58,971 2020-06-05 1

VAN HOVE CAROLINE F.

  • Director
43,986 2020-06-05 3

NUGENT JEFFREY M CHAIRMAN OF THE BOARD AND CEO

  • Officer
  • Director
200,511 2020-05-01 2

LITTLE PAUL SEAN CHIEF FINANCIAL OFFICER

  • Officer
91,722 2020-05-01 1

BENNETT OLIVER CHRISTIAN GENERAL COUNSEL AND VP

  • Officer
28,069 2020-05-01 2

HAINES TIMOTHY

  • FORMER DIRECTOR AND 10% OWNER
2,144,517 2019-11-12 0

HUINER CHARLES COO & SVP CORP. DEV. STRATEGY

  • Officer
164,474 2019-04-05 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP III LLC

ISALY SAMUEL D

  • 10% Owner
5,550,000 2018-01-03 0

GUPTA RISHI

  • Director
0 2016-05-19 0

PIGEON MATTHEW CFO AND TREASURER

  • Officer
141,248 2016-01-26 0

ZEINI HANI M

  • Director
0 2015-09-23 0

SMITH JOEL S. GC, SECRETARY AND CCO

  • Officer
0 2014-10-28 0

CLARUS LIFESCIENCES I, L.P.

CLARUS VENTURES I MANAGEMENT, L.P.

CLARUS VENTURES I, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

WHEELER KURT

  • 10% Owner
2,730,765 2014-10-28 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments